Amniotic mesenchymal cells are seen in amniotic membranes and fluid.
Only one chance in life exists to save those cells and that is during the delivery
of your newborn baby without any risks to anyone involved.
In recent and ongoing clinical trials, amniotic mesenchymal stem cells demonstrate great therapeutic potential that holds great promise in the future of regenerative medicine especially for various degenerative and inflammatory conditions without current treatment options.
The role of those cells: is to maintain the integrity of the amniotic membranes and ensure a safe pregnancy.
Properties of Amniotic Mesenchymal Stromal Cells.
Their immense expansion potential is being elucidated and unfolding in numerous recent clinical trials.
These cells produce cytokines that can modulate inflammation and the immune system.
In similarity to other MSC, these cells can avoid immune detection as they do not yet present HLA antigens used in adult immune systems to detect foreign cells.
ONGOING CLINICAL TRIALS: Due to their vast expansion potential, these cells demonstrate potential in conditions related to almost all organ systems. Numerous clinical trials are currently investigating this immense potential.
Renal and Urinary system
system- Orthopedic surgery
and Immunological systems
Eye and ENT surgery
Amniotic MSC could be the cornerstone of future regenerative medicine, especially for various degenerative and inflammatory conditions without current treatment options. (click)